Search

everythinglearnresearchcommunity

for

Search:↓

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Thymic stromal lymphopoietin (TSLP) promotes hair growth by stimulating specific skin cells.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Thyroid receptor agonists may treat male pattern baldness without harmful side effects.

Activated ras can protect kidney cells from a certain substance that causes cell death.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

RTA 408 cream protects mice from radiation skin damage.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.